Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy - Wikidata - awgldk - TriplyDB

Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy

Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy

http://www.wikidata.org/entity/Q36971369

about

The potential of pathological protein fragmentation in blood-based biomarker development for dementia - with emphasis on Alzheimer's disease Advances in understanding spontaneous intracerebral hemorrhage: insights from neuroimaging.Cerebral amyloid angiopathy: emerging concepts Biomarkers in translational research of Alzheimer's disease Interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals.Dissociated amyloid-beta antibody levels as a serum biomarker for the progression of Alzheimer's disease: a population-based study.Brain microbleeds and Alzheimer's disease: innocent observation or key player?Outcome markers for clinical trials in cerebral amyloid angiopathy.Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.Cerebral amyloid angiopathy in the elderly New therapeutic approaches for Alzheimer's disease and cerebral amyloid angiopathy.The overlap between vascular disease and Alzheimer's disease--lessons from pathology.Cerebral amyloid angiopathy increases susceptibility to infarction after focal cerebral ischemia in Tg2576 mice Advances in our Understanding of the Pathophysiology, Detection and Management of Cerebral Amyloid Angiopathy.Biomarkers predicting Alzheimer's disease in cognitively normal aging.Cerebral amyloid angiopathy-related atraumatic convexal subarachnoid hemorrhage: an ARIA before the tsunami CSF biomarkers for Alzheimer's disease: current utility and potential future use.Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer's disease Cerebral white matter lesions - associations with Aβ isoforms and amyloid PET Cerebrospinal fluid profiles with increasing number of cerebral microbleeds in a continuum of cognitive impairment.Corticosteroid therapy in a patient with cerebral amyloid angiopathy-related inflammation.Stroke prevention in atrial fibrillation in older adults: existing knowledge gaps and areas for innovation: a summary of an American Federation for Aging research seminar.Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations.Review: sporadic cerebral amyloid angiopathy.18F-AV-1451 PET Imaging in Three Patients with Probable Cerebral Amyloid Angiopathy.The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice.Alzheimer's disease CSF biomarkers: clinical indications and rational use.Cerebral microbleeds as a biomarker in Alzheimer's disease? A review in the field.Elevated Plasma Aβ42 in Cognitively Impaired Individuals Taking ACE Inhibitor Antihypertensives.Pseudotumoral presentation of cerebral amyloid angiopathy-related inflammation.APP Mutations in Cerebral Amyloid Angiopathy with or without Cortical Calcifications: Report of Three Families and a Literature Review.Dissecting IWG-2 typical and atypical Alzheimer's disease: insights from cerebrospinal fluid analysis.Predicting cerebral amyloid angiopathy-related intracerebral hemorrhages and other cerebrovascular disorders in Alzheimer's disease.Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation.Cerebrospinal Fluid Anti-Amyloid-β Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation.Thrombolysis-related Multiple Lobar Hemorrhaging in Cerebral Amyloid Angiopathy with Extensive Strictly Lobar Cerebral Microbleeding.Florbetapir-PET to diagnose cerebral amyloid angiopathy: A prospective study.Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteria.β-Amyloid in CSF: Biomarker for preclinical cerebral amyloid angiopathy.Passive immunotherapy targeting amyloid-β reduces cerebral amyloid angiopathy and improves vascular reactivity.

P2860

Q26853347-A0E6E623-AAAC-42F3-B4AD-1C981BB2F20E Q30825729-EE18CF0D-C77C-4BF7-BF04-AA6769B4C1D1 Q30894798-D24D440B-F9F6-4F66-8030-9AA51D875922 Q33556189-B2209B04-1568-49C9-BA56-B9F4172BB109 Q33616238-37D58BEF-ED68-47FE-A82F-3D63C68D5021 Q33625476-4563F0DE-5972-4E59-BA23-3941562322B2 Q33800668-B48F807F-2E4A-4E61-BDE9-124EC59D73B7 Q33859442-2AFE6D12-D8A1-44E8-B146-7CDBEF300C9F Q33967781-3A961A59-3628-4589-88A5-C21657C22EB9 Q34108298-52796FBE-9F2F-4467-80B7-B2811184D81F Q34368970-DD340F13-B5ED-45AF-983F-80BAC0A074F1 Q34484708-2F2A2743-D741-44A4-A987-A2DAC60B8B2D Q34889214-D9EB733A-140E-436C-8503-7A921C9AA944 Q34994148-94CFA6C1-1AD0-4E5A-9A8D-6D4200D4ED24 Q35091673-C599038D-422B-41A9-8A38-E0D9744DD51E Q35572825-F68AB206-D657-4A78-BCF6-D39A07DF8E77 Q35600993-084139D8-0B52-4F09-9945-9405E989B3F3 Q36383749-C28200B1-E269-4828-AE20-55B57996E763 Q36559869-4288CA1F-7BC4-492D-8AD9-60F24B680904 Q36692487-38874364-F744-4874-82FF-145CE2486460 Q36793903-A7451583-CD1C-4DFF-B7D8-7D0C70B569BC Q37241354-EA08EDE3-E86A-4737-AC07-5F6896830449 Q37435248-3FF85EA2-B3EB-4442-B5AB-B201430044A8 Q37800132-48AE2D58-591F-4A22-99AD-055D045DDDA9 Q38404963-8771C1EF-F657-41E9-A073-238BB38C4A04 Q38636940-B6BA3AA3-EE48-4689-95C8-BE0AFB18982F Q38650548-CAC823E9-C6F3-4ABD-97E2-F496379D5AA6 Q38660991-2AFB6EC4-B9BA-4901-838F-E88772271DE0 Q38690145-862A63F2-DE24-4436-80BE-3211B6E62E5D Q38833788-7C522B58-CEBE-46D3-9ED2-2274375AB954 Q39011999-7A450AA2-F417-4C98-A911-3C326B825115 Q39342351-E4301A04-5357-4599-A25D-A1786461628E Q39624124-48D2600D-534B-495E-9DF2-442919C105E8 Q40117554-D507BE7B-341B-49A7-9868-A670683A7503 Q40239774-EBBA9852-8816-4B95-8635-643DA81F5A17 Q41308093-435C59DE-A368-4343-873A-3C65D470FB3B Q45425671-08CC53E8-189A-40F9-B3C3-19BFB9BAE2BA Q46130150-9A11AD70-1229-451A-9F2C-82822C8D303D Q46452092-625AA9C8-88FD-406D-93F5-6E0434AF9895 Q46650071-29BB2DF1-8B3A-4D1A-8A54-AA02941C2266

P2860

Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy

http://www.wikidata.org/entity/Q36971369

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy

@en

type

label

Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy

@en

prefLabel

Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy

@en

P1433

Q36971369-5F100EE8-D0A4-469E-981C-48954A59E4CD

P1476

Q36971369-3EA95FE6-B4B5-475A-A6ED-F20BE32B382C

P2093

Q36971369-35D65621-978D-4B8B-81EF-D67FD0117E08

Q36971369-5F2FD1C6-ADFD-48B5-B670-5D10F11FBEE5

Q36971369-6DA93162-CE28-438B-B322-00E34DC263A6

Q36971369-6EC20611-6990-4A8A-B3EC-290F9A2FEB7C

Q36971369-970F50AC-830E-4123-B526-CBBD968685DF

Q36971369-C50E6EBA-D253-4055-A3A1-7738E29FCB03

P2860

Q36971369-4C05E6E6-DE12-4A4D-B902-F670F811817A

Q36971369-8645389E-CE37-4B37-A1B0-F40023AE8112

Q36971369-8AE5C8EA-FFC6-4FC1-B444-AE5F140DC048

Q36971369-9B0C7706-AA95-4848-AF8D-097314C74E85

Q36971369-A1F44576-F3D1-44E2-8B8C-2CA896DAFFBD

Q36971369-A5FC7FE1-D4E3-4206-AC08-D27CCAF5F8B2

Q36971369-B2483EB2-0345-4D03-B4D7-A4AFB11F5C1E

Q36971369-B2579C7D-02F4-48D9-B5CF-E262D85CCF97

Q36971369-B52044CF-15C3-4512-9ECD-7573B8E5EFF4

Q36971369-B594C6A1-37D9-45DC-BEBE-B0C54F0D789A

P304

Q36971369-32AD2E70-2664-4111-B1F0-E52FAACF320F

P31

Q36971369-01AE2D67-B226-4853-B082-C54F07923CA9

P356

Q36971369-52137F14-4ABA-4C04-8D41-A9125B99BB92

P433

Q36971369-E8B6EF1D-99A8-4824-8B3A-50A863132370

P478

Q36971369-094EFC71-1414-4E5C-B9C6-ABDB6AF2A14C

P577

Q36971369-A59E0220-C031-4C8F-94B0-13B973B2BDC8

P5875

Q36971369-FCF743A5-9E15-4682-87C7-4D13FF56365A

P698

Q36971369-572C728D-BAB5-4AE7-89DA-0F1A3378195A

P921

Q36971369-40B69F2E-8B16-4CEB-B0BF-7821B0265C44

P932

Q36971369-80D49F7C-92A7-4C05-A254-45834667ED47

P356

P1433

Annals of Neurology

P1476

Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy

@en

P2093

Berry P H Kremer

http://www.w3.org/2001/XMLSchema#string

Marcel M Verbeek

http://www.w3.org/2001/XMLSchema#string

Marcel Olde Rikkert

http://www.w3.org/2001/XMLSchema#string

Maureen E Skehan

http://www.w3.org/2001/XMLSchema#string

Peter H M F Van Domburg

http://www.w3.org/2001/XMLSchema#string

Steven M Greenberg

http://www.w3.org/2001/XMLSchema#string

P2860

Amyloid angiopathy-related vascular cognitive impairment.

Current state and future directions of neurochemical biomarkers for Alzheimer's disease.

Abeta-degrading enzymes in Alzheimer's disease.

Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease.

Impaired visual evoked flow velocity response in cerebral amyloid angiopathy

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.

Brain parenchymal and microvascular amyloid in Alzheimer's disease.

Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy.

Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor.

Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).

P304

245-249

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.21694

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26801775

http://www.w3.org/2001/XMLSchema#string

P698

19743453

http://www.w3.org/2001/XMLSchema#string

P921

cerebrospinal fluid

P932

3697750

http://www.w3.org/2001/XMLSchema#string